GT Biopharma, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
GT Biopharma, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2023.
  • GT Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $6.27M.
  • GT Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6.27M.
  • GT Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$224K, a 101% decline from 2021.
  • GT Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $42.3M, a 238% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $6.27M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2021 $25.9M +$25.7M +12871% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $200K -$752K -79% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $952K -$5.57M -85.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q1 2018 $6.52M +$5.66M +653% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q1 2017 $866K +$716K +477% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 $150K -$2.2M -93.6% Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-02-28
Q1 2015 $2.35M +$2.3M +4600% Jan 1, 2015 Mar 31, 2015 10-Q/A 2018-02-28
Q1 2014 $50K +$49K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q1 2013 $1K* -$219K Jan 1, 2013 Mar 31, 2013 10-Q 2015-01-08
Q1 2012 $220K +$126K +134% Jan 1, 2012 Mar 31, 2012 10-Q 2014-12-10
Q1 2011 $94K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.